Table 1. Demographic and clinical characteristics and patterns of antipsychotic use in 1,765 outpatients with schizophrenia.
Values are frequencies (%) or means ± standard deviations.
| Variable | Without AP (n = 31) | Monotherapy (n = 505) | Polypharmacy (n = 1,229) |
|---|---|---|---|
| Gender | |||
| Male | 19 (61.3) | 330 (65.3) | 868 (70.6) |
| Female | 12 (38.7) | 175 (34.7) | 361 (29.4) |
| Age | 45.58±13.04 | 45.82±13.80 | 42.64±13.44 |
| Marital status | |||
| Single | 23 (74.2) | 327 (64.8) | 861 (70.1) |
| Married / Domestic Partner | 6 (19.4) | 74 (14.7) | 154 (12.5) |
| Separated / Divorced | 1 (3.2) | 32 (6.3) | 63 (5.1) |
| Widowed | - | 8 (1.6) | 13 (1.1) |
| Unknown/Not reported | 1 (3.2) | 64 (12.7) | 138 (11.2) |
| Schizophrenia subtype | |||
| F20.0 Paranoid | 21 (67.7) | 343 (67.9) | 929 (75.6) |
| F20.1 Hebephrenic | - | 13 (2.6) | 33 (2.7) |
| F20.2 Catatonic | - | 2 (0.4) | 2 (0.2) |
| F20.3 Undifferentiated | 4 (12.9) | 31 (6.1) | 64 (5.2) |
| F20.4 Post-schizophrenic depression | - | - | 1 (0.1) |
| F20.5 Residual | 3 (9.7) | 66 (13.1) | 109 (8.9) |
| F20.6 Simple | - | 21 (4.2) | 40 (3.3) |
| F20.8 Other | 1 (3.2) | 2 (0.4) | 11 (0.9) |
| F20.9 Unspecified | 2 (6.5) | 27 (5.3) | 40 (3.3) |
| SMD | 17 (54.8) | 312 (61.8) | 815 (66.3) |
| Principal Antipsychotic | |||
| Typical | - | 72 (14.3) | 263 (21.4) |
| Atypical | - | 433 (85.7) | 966 (78.6) |
| Psychiatric co-medication | 12 (38.7) | 340 (67.3) | 1,085 (88.3) |
| Psychiatric co-morbidity | 6 (19.4) | 157 (31.1) | 543 (44.2) |
| Consumption of substances | 5 (41.7) | 120 (54.5) | 446 (68.9) |
| Duration of disease (months) | 162.67±96.25 | 167.63±86.46 | 167.15±85.64 |
Note. SMD = Severe Mental Disorder. Values significantly different (according to Pearson’s Chi square or the Kruskal Wallis test) are in bold (p<0.01).